4//SEC Filing
Quane Alessandrea C. 4
Accession 0001562180-24-008101
CIK 0001568651other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:16 PM ET
Size
19.9 KB
Accession
0001562180-24-008101
Insider Transaction Report
Form 4
Quane Alessandrea C.
EVP, Chief Insurance Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-12-01+7,015→ 399,622 total - Exercise/Conversion
Class A Common Stock
2024-12-01+8,653→ 442,654 total - Exercise/Conversion
Restricted Stock Units
2024-12-01−8,653→ 77,872 total→ Class A Common Stock (8,653 underlying) - Exercise/Conversion
Class A Common Stock
2024-12-01+34,379→ 434,001 total - Sale
Class A Common Stock
2024-12-02$18.07/sh−26,411$477,247→ 416,243 total - Exercise/Conversion
Restricted Stock Units
2024-12-01−7,015→ 21,048 total→ Class A Common Stock (7,015 underlying) - Sale
Class A Common Stock
2024-12-02$18.48/sh−484$8,944→ 415,759 total - Exercise/Conversion
Restricted Stock Units
2024-12-01−34,379→ 309,417 total→ Class A Common Stock (34,379 underlying)
Holdings
- 76,857(indirect: Alessandrea C Quane 2024 GRAT)
Class A Common Stock
Footnotes (7)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.
- [F6]The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
- [F7]The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.
Documents
Issuer
Oscar Health, Inc.
CIK 0001568651
Entity typeother
Related Parties
1- filerCIK 0001667819
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 4:16 PM ET
- Size
- 19.9 KB